Concord Healthcare Grp Co Ltd (2453.HK)
HKD 13.74
(-2.69%)
HKD 13.74
(-2.69%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 538.65 Million | 549.07 Million | 567.05 Million | 186.89 Million | 143.6 Million |
| Cost of Revenue | 676.65 Million | 746.53 Million | 659.81 Million | 204.16 Million | 126.79 Million |
| Gross Profit | -138 Million | -197.45 Million | -92.75 Million | -17.27 Million | 16.81 Million |
| Operating Expenses | 311.21 Million | 358.81 Million | 376.27 Million | 283.29 Million | 168.77 Million |
| Selling, General and Administrative Expenses | 252.96 Million | 311.49 Million | 329.82 Million | 272.12 Million | 164.84 Million |
| Research and Development Expenses | 36.44 Million | 47.43 Million | 48.22 Million | 12.62 Million | 3.33 Million |
| Other Expenses | 230.94 Thousand | 117.44 Thousand | 1.77 Million | 1.45 Million | -590.77 Thousand |
| Cost and Expenses | 987.87 Million | 1.1 Billion | 1.03 Billion | 487.45 Million | 295.57 Million |
| Operating Income | -353.66 Million | -556.26 Million | -469.02 Million | -300.56 Million | -151.96 Million |
| Interest Expense | 108 Million | 274.47 Million | 435.31 Million | 323.47 Million | 277.09 Million |
| Income Tax Expense | -6.19 Million | -11.56 Million | -6.27 Million | -7.26 Million | -3.11 Million |
| Earnings before Tax | -432.59 Million | -752.32 Million | -1 Billion | -671.67 Million | -318.86 Million |
| Net Income | -373.09 Million | -629.58 Million | -984.16 Million | -655.4 Million | -318.51 Million |
| Earnings Per Share Basic | -0.52 | -0.88 | -1.37 | -0.91 | -1.99 |
| Earnings Per Share Diluted | -0.52 | -0.88 | -1.37 | -0.91 | -1.99 |
| Weighted Average Shares Outstanding | 716.33 Million | 716.33 Million | 716.33 Million | 716.33 Million | 160 Million |
| Weighted Average Shares Outstanding (Diluted) | 716.33 Million | 716.33 Million | 716.33 Million | 716.33 Million | 160 Million |
| Gross Margin | -0.26 | -0.36 | -0.16 | -0.09 | 0.12 |
| EBIT Margin | -0.32 | -0.70 | -0.58 | -1.10 | -0.66 |
| Profit Margin | -0.69 | -1.15 | -1.74 | -3.51 | -2.22 |
| EBITDA | -172.57 Million | -224.64 Million | -287.01 Million | -190.4 Million | -95.48 Million |
| Earnings Before Tax Margin | -0.66 | -1.01 | -0.83 | -1.61 | -1.06 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 117.65 Million | 118.66 Million | 595.2 Million | 273.83 Million | 135.93 Million | 322.52 Million |
| Cost of Revenue | 136.19 Million | 137.36 Million | 676.65 Million | 306.37 Million | 152.08 Million | 377.66 Million |
| Gross Profit | -18.53 Million | -18.69 Million | -81.45 Million | -32.53 Million | -16.15 Million | -55.14 Million |
| Operating Expenses | 64.76 Million | 65.32 Million | 311.21 Million | 168.18 Million | 71.96 Million | 136.62 Million |
| Selling, General and Administrative Expenses | 57.17 Million | 57.66 Million | - | 148.82 Million | 76.01 Million | 116.52 Million |
| Research and Development Expenses | 7.59 Million | 7.65 Million | - | 19.36 Million | 9.61 Million | 20.32 Million |
| Other Expenses | 81.26 Thousand | - | 230.94 Thousand | 6480.00 | - | 229.58 Thousand |
| Cost and Expenses | 200.95 Million | 202.68 Million | 987.87 Million | 474.55 Million | 224.04 Million | 514.29 Million |
| Operating Income | -83.3 Million | -84.01 Million | -392.66 Million | -200.71 Million | -104.2 Million | -191.76 Million |
| Interest Expense | 86.49 Million | - | 108 Million | 88.04 Million | - | 95.87 Million |
| Income Tax Expense | 1.34 Million | 1.35 Million | -6.84 Million | -2.23 Million | 1.11 Million | -4.66 Million |
| Earnings before Tax | -109.88 Million | -110.82 Million | -476.09 Million | -230.85 Million | -114.87 Million | -245.6 Million |
| Net Income | -97.71 Million | -98.55 Million | -412.26 Million | -193.17 Million | -95.89 Million | -219.71 Million |
| Earnings Per Share Basic | -0.14 | -0.14 | - | -0.27 | -0.14 | -0.31 |
| Earnings Per Share Diluted | -0.14 | -0.14 | - | -0.27 | -0.14 | -0.31 |
| Weighted Average Shares Outstanding | 714.64 Million | 714.64 Million | 716.33 Million | 716.33 Million | 676.92 Million | 716.33 Million |
| Weighted Average Shares Outstanding (Diluted) | 714.64 Million | 714.64 Million | 716.33 Million | 716.33 Million | 676.91 Million | 716.33 Million |
| Gross Margin | -0.16 | -0.16 | -0.14 | -0.12 | -0.12 | -0.17 |
| EBIT Margin | -0.43 | -0.43 | - | -0.43 | -0.54 | -0.33 |
| Profit Margin | -0.83 | -0.83 | -0.69 | -0.71 | -0.71 | -0.68 |
| EBITDA | -50.55 Million | -50.98 Million | - | -119.11 Million | -73.53 Million | -105.28 Million |
| Earnings Before Tax Margin | -0.71 | -0.71 | -0.66 | -0.73 | -0.77 | -0.59 |
ADF
ASSF
0RG7
HEAL
WFHG
NATURAL